
CAS 1254473-64-7
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 7 produtos.
Ref: IN-DA000NOR
neA consultar1gA consultar250mgA consultar5mg68,00€1mg69,00€10mg110,00€25mg174,00€50mg211,00€100mg357,00€(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-Yl)Ethoxy)-1H-Indazol-3-Yl)Vinyl)-1H-Pyrazol-1-Yl)Ethan-1-Ol
CAS:(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-Yl)Ethoxy)-1H-Indazol-3-Yl)Vinyl)-1H-Pyrazol-1-Yl)Ethan-1-OlFórmula:C21H19Cl2N5O2Pureza:98%Peso molecular:444.31LY2874455
CAS:(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethan-1-olFórmula:C21H19Cl2N5O2Pureza:98%Peso molecular:444.31LY2874455
CAS:LY2874455 has been used in trials studying the treatment of Advanced Cancer.Fórmula:C21H19Cl2N5O2Pureza:99.37% - 99.72%Cor e Forma:Yellow SolidPeso molecular:444.31Ref: TM-T2361
1mg47,00€5mg92,00€1mL*10mM (DMSO)101,00€10mg145,00€25mg281,00€50mg447,00€100mg670,00€200mg888,00€LY 2874455
CAS:Inhibitor of FGFR kinase
Fórmula:C21H19Cl2N5O2Pureza:(%) Min. 98%Peso molecular:443.09158LY 2874455
CAS:Produto ControladoApplications LY 2874455 is a pan-FGFR inhibitor which remain the focus of research for use in lung and bladder cancers.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Gozgit, J. et al.: Mol. Cancer Ther., 11, 690 (2012); Zhao, G. et al.: Mol. Cancer Ther., 10, 2200 (2011);Fórmula:C21H19Cl2N5O2Cor e Forma:NeatPeso molecular:444.31





